The Queensland University of Technology is a public research university located in the urban coastal city of Brisbane, Queensland, Australia. QUT is located on two campuses in the Brisbane area viz. Gardens Point and Kelvin Grove.

During the past decade, Queensland University of Technology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Queensland University of Technology" are "Alzheimer Disease" (1 trials) and "Alzheimer's Disease" (1 trials). Many other conditions were trialed in "Queensland University of Technology" in a lesser frequency.

Most popular intervention types in "Queensland University of Technology" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Gantenerumab" (1 trials), "Semorinemab" (1 trials) and "[18F]GTP1" (1 trials). Other intervention names were less common.

The vast majority of trials in "Queensland University of Technology" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Queensland University of Technology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Queensland University of Technology, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Queensland University of Technology, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".